MedPath

Sitavio 50mg Film Coated Tablets

Registration Number: MAL22126053AZ

Approved
Approval ID

40df1e89335a130d

Registration Number

MAL22126053AZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types6 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (6)

1X10 TabletsAvailable
Package Size: 1X10 Tablets
Status: NPRA Approved
3X10 TabletsAvailable
Package Size: 3X10 Tablets
Status: NPRA Approved
6X10 TabletsAvailable
Package Size: 6X10 Tablets
Status: NPRA Approved
10X10 TabletsAvailable
Package Size: 10X10 Tablets
Status: NPRA Approved
50X10 TabletsAvailable
Package Size: 50X10 Tablets
Status: NPRA Approved
100X10 TabletsAvailable
Package Size: 100X10 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

Sitagliptin Phosphate MonohydrateActive
Monograph: 西格列汀

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sitavio 50mg Film Coated Tablets - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform